Evaluation of prognostic factors on survival in non-small-cell lung cancer patients treated with postoperative radiotherapy

被引:0
作者
Sarihan, Sureyya [1 ]
Gebitekin, Cengiz [2 ]
Bayram, Ahmet Sami [2 ]
Ercan, Ilker [3 ]
Evrensel, Turkkan [4 ]
Akyildiz, Elif Ulker [5 ]
机构
[1] Uludag Univ, Tip Fak, Radyasyon Onkol Anabilim Dali, Bursa, Turkey
[2] Uludag Univ, Tip Fak, Gogus Cerrahisi Anabilim Dali, Bursa, Turkey
[3] Uludag Univ, Tip Fak, Biyoistat Anabilim Dali, Bursa, Turkey
[4] Uludag Univ, Tip Fak, Med Onkol Bilim Dali, Bursa, Turkey
[5] Uludag Univ, Tip Fak, Patol Anabilim Dali, Bursa, Turkey
来源
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY | 2009年 / 24卷 / 02期
关键词
Non-small-cell lung cancer; postoperative radiotherapy; prognostic factors; survival;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVES To investigate the prognostic factors on survival in non-small-cell lung cancer patients treated with postoperative radiotherapy. METHODS Sixty-five patients treated with a median dose of 59 Gy (50-66.6 Gy) between October 1995 and January 2005 were included in the study. Clinical and categorical variables were analyzed. RESULTS On multivariate analysis, presence of clinical N2 and brain metastasis at first relapse and absence of chemotherapy (p=0.02, p=0.004, p=0.004) had a negative impact on overall survival, while presence of pathological nodal involvement and absence of chemotherapy (p=0.02, p=0.04) were effective on disease-free survival. Regarding categorical variables, type of resection was found related with positive margin and N1, right-sided location with N1-e and N2, and systematic nodal dissection with N1. The number of involved lymph nodes was found related with N2 skip metastasis and involved N1-10 was related with N1-e. CONCLUSION Presence of metastatic lymph nodes was found to be a poor prognostic factor and delivery of chemotherapy was seen to positively affect overall and disease-free survival rates.
引用
收藏
页码:53 / 64
页数:12
相关论文
共 40 条
  • [1] Prognostic factors in stage III non-small-cell lung cancer
    Ademuyiwa, Foluso O.
    Johnson, Cynthia S.
    White, Angela S.
    Breen, Timothy E.
    Harvey, Jayme
    Neubauer, Marcus
    Hanna, Nasser H.
    [J]. CLINICAL LUNG CANCER, 2007, 8 (08) : 478 - 482
  • [2] [Anonymous], 1988, J Thorac Cardiovasc Surg, V95, P883
  • [3] Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer
    Bekelman, Justin E.
    Rosenzweig, Kenneth E.
    Bach, Peter B.
    Schrag, Deborah
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : 492 - 499
  • [4] Localized non-small cell lung cancer: Adjuvant radiotherapy in the era of effective systemic therapy
    Bogart, JA
    Aronowitz, JN
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5004S - 5010S
  • [5] Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the radiation therapy oncology group - RTOG 9705
    Bradley, JD
    Paulus, R
    Graham, MV
    Ettinger, DS
    Johnstone, DW
    Pilepich, MV
    Machtay, M
    Komaki, R
    Atkins, J
    Curran, WJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3480 - 3487
  • [6] Burdett S, 1998, LANCET, V352, P257
  • [7] Dautzenberg B, 1999, CANCER-AM CANCER SOC, V86, P265, DOI 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO
  • [8] 2-B
  • [9] Dincbas FO, 2007, DISPNE, P38
  • [10] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial
    Douillard, Jean-Yves
    Rosell, Rafael
    De Lena, Mario
    Carpagnano, Francesco
    Ramlau, Rodryg
    Gonzales-Larriba, Jose Luis
    Grodzki, Tornasz
    Pereira, Jose Rodrigues
    Le Groumellec, Alain
    Lorusso, Vito
    Clary, Claude
    Torres, Antonio J.
    Dahabreh, Jabrail
    Souquet, Pierre-Jean
    Astudillo, Julio
    Fournel, Pierre
    Artal-Cortes, Angel
    Jassem, Jacek
    Koubkova, Leona
    His, Patricia
    Riggi, Marcella
    Hurteloup, Patrick
    [J]. LANCET ONCOLOGY, 2006, 7 (09) : 719 - 727